S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Karyopharm Therapeutics News Headlines (NASDAQ:KPTI)

$11.13
+0.43 (+4.02 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$10.70
Now: $11.13
$11.35
50-Day Range
$8.22
MA: $10.06
$11.67
52-Week Range
$3.92
Now: $11.13
$12.49
Volume1.34 million shs
Average Volume1.78 million shs
Market Capitalization$689.18 million
P/E RatioN/A
Dividend YieldN/A
Beta2.42

Headlines

Karyopharm Therapeutics (NASDAQ KPTI) News Headlines

Source:
DateHeadline
If You Had Bought Karyopharm Therapeutics (NASDAQ:KPTI) Stock Five Years Ago, Youd Be Sitting On A 71% Loss, TodayIf You Had Bought Karyopharm Therapeutics (NASDAQ:KPTI) Stock Five Years Ago, You'd Be Sitting On A 71% Loss, Today
finance.yahoo.com - October 21 at 12:42 PM
If You Had Bought Karyopharm Therapeutics (NASDAQ:KPTI) Stock Five Years Ago, You'd Be Sitting On A 71% Loss, TodayIf You Had Bought Karyopharm Therapeutics (NASDAQ:KPTI) Stock Five Years Ago, You'd Be Sitting On A 71% Loss, Today
finance.yahoo.com - October 21 at 12:42 PM
 Analysts Anticipate Karyopharm Therapeutics Inc (NASDAQ:KPTI) to Announce -$0.84 EPS Analysts Anticipate Karyopharm Therapeutics Inc (NASDAQ:KPTI) to Announce -$0.84 EPS
www.americanbankingnews.com - October 9 at 3:19 AM
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Given Average Recommendation of "Buy" by AnalystsKaryopharm Therapeutics Inc (NASDAQ:KPTI) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - October 8 at 6:05 AM
Robert W. Baird Reiterates $25.00 Price Target for Karyopharm Therapeutics (NASDAQ:KPTI)Robert W. Baird Reiterates $25.00 Price Target for Karyopharm Therapeutics (NASDAQ:KPTI)
www.americanbankingnews.com - September 26 at 10:55 PM
CLASS ACTION UPDATE for MMM, KPTI, GTT and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for MMM, KPTI, GTT and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
www.globenewswire.com - September 23 at 5:07 PM
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmMONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
feeds.benzinga.com - September 23 at 9:10 AM
KARYOPHARM 24 HOUR DEADLINE ALERT: FORMER...KARYOPHARM 24 HOUR DEADLINE ALERT: FORMER...
www.benzinga.com - September 23 at 4:10 AM
KARYOPHARM 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTIKARYOPHARM 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTI
finance.yahoo.com - September 22 at 11:09 PM
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the FirmDEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the Firm
finance.yahoo.com - September 21 at 2:34 PM
KARYOPHARM 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTIKARYOPHARM 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTI
www.businesswire.com - September 21 at 1:30 AM
KARYOPHARM 72 HOUR DEADLINE ALERT: Former...KARYOPHARM 72 HOUR DEADLINE ALERT: Former...
www.benzinga.com - September 20 at 11:35 PM
KARYOPHARM 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTIKARYOPHARM 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTI
finance.yahoo.com - September 20 at 11:35 PM
Even More Implied Analyst Upside for Karyopharm Therapeutics After Royalty PactEven More Implied Analyst Upside for Karyopharm Therapeutics After Royalty Pact
www.msn.com - September 18 at 7:39 PM
Pomerantz Law Firm Announces the Filing of a Class Action against Karyopharm Therapeutics Inc. and Certain Officers – KPTIPomerantz Law Firm Announces the Filing of a Class Action against Karyopharm Therapeutics Inc. and Certain Officers – KPTI
finance.yahoo.com - September 18 at 7:39 PM
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPTI, NGHC and GTTThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPTI, NGHC and GTT
www.baystreet.ca - September 16 at 3:18 PM
Karyopharm sells selinexor royalties for up to $150M; shares up 3% premarketKaryopharm sells selinexor royalties for up to $150M; shares up 3% premarket
seekingalpha.com - September 16 at 11:16 AM
Karyopharm inks royalty agreement with HCR; shares up 3% premarketKaryopharm inks royalty agreement with HCR; shares up 3% premarket
seekingalpha.com - September 16 at 11:16 AM
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Karyopharm Therapeutics, Inc.Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Karyopharm Therapeutics, Inc.
finance.yahoo.com - September 16 at 11:16 AM
SHAREHOLDER ALERT - Karyopharm Therapeutics Inc. (KPTI) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders With Losses Exceeding $100K of Class Action and Lead Deadline: September 23, 2019SHAREHOLDER ALERT - Karyopharm Therapeutics Inc. (KPTI) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders With Losses Exceeding $100K of Class Action and Lead Deadline: September 23, 2019
finance.yahoo.com - September 16 at 11:16 AM
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
www.benzinga.com - September 16 at 9:14 AM
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of OMCL, KPTI and NGHCFILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of OMCL, KPTI and NGHC
finance.yahoo.com - September 15 at 11:10 AM
Zhang Investor Law Reminds Investors of September 23 Deadline in Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTIZhang Investor Law Reminds Investors of September 23 Deadline in Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTI
finance.yahoo.com - September 14 at 1:28 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, EGBN and MNKThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, EGBN and MNK
finance.yahoo.com - September 12 at 10:44 PM
Karyopharm Therapeutics (KPTI) Presents At Baird Global Healthcare Conference - SlideshowKaryopharm Therapeutics (KPTI) Presents At Baird Global Healthcare Conference - Slideshow
seekingalpha.com - September 12 at 5:43 PM
SEPTEMBER DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmSEPTEMBER DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 12 at 5:42 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Karyopharm Therapeutics Inc. - KPTISHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
finance.yahoo.com - September 12 at 5:42 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, GVA and IFFThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, GVA and IFF
finance.yahoo.com - September 12 at 5:42 PM
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Karyopharm Therapeutics Inc. Investors of Important September 23rd Deadline in Securities Class Action – KPTIROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Karyopharm Therapeutics Inc. Investors of Important September 23rd Deadline in Securities Class Action – KPTI
finance.yahoo.com - September 12 at 5:42 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RBGLY, KPTI, PS and TXTThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RBGLY, KPTI, PS and TXT
www.benzinga.com - September 11 at 12:36 PM
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of OMCL, KPTI and GVAFILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of OMCL, KPTI and GVA
finance.yahoo.com - September 11 at 12:36 PM
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Karyopharm Therapeutics Inc.  To Contact The FirmLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Karyopharm Therapeutics Inc.  To Contact The Firm
finance.yahoo.com - September 10 at 12:46 PM
CLASS ACTION UPDATE for LB, KPTI and IFF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for LB, KPTI and IFF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - September 10 at 12:46 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OMCL, KPTI and VALThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OMCL, KPTI and VAL
finance.yahoo.com - September 9 at 8:50 PM
SEPTEMBER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmSEPTEMBER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 8 at 7:29 AM
Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTIZhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTI
finance.yahoo.com - September 7 at 12:38 PM
FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmFINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 6 at 2:52 PM
SHAREHOLDER ALERT: VNTR KPTI TWOU: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesSHAREHOLDER ALERT: VNTR KPTI TWOU: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
www.baystreet.ca - September 5 at 5:13 PM
SHAREHOLDER ALERT: RBGLY LB KPTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesSHAREHOLDER ALERT: RBGLY LB KPTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
finance.yahoo.com - September 5 at 5:13 PM
IMPORTANT SEPTEMBER DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT SEPTEMBER DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 3 at 8:01 PM
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmUPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - September 3 at 8:50 AM
CLASS ACTION UPDATE for KPTI, NGHC and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for KPTI, NGHC and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - August 30 at 12:07 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, JE, GTT and VALThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, JE, GTT and VAL
finance.yahoo.com - August 28 at 12:00 PM
KPTI, MNK & NGHC - Bronstein, Gewirtz & Grossman, LLC - Class ActionKPTI, MNK & NGHC - Bronstein, Gewirtz & Grossman, LLC - Class Action
finance.yahoo.com - August 28 at 12:00 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, JE and IFFThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, JE and IFF
finance.yahoo.com - August 27 at 8:35 AM
Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc. – KPTIZhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc. – KPTI
finance.yahoo.com - August 27 at 8:35 AM
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 26 at 7:44 PM
BRIEF-Karyopharm Announces Publication Of Xpovio (Selinexor) Phase 2b Storm Study Results In The New England Journal Of MedicineBRIEF-Karyopharm Announces Publication Of Xpovio (Selinexor) Phase 2b Storm Study Results In The New England Journal Of Medicine
www.msn.com - August 22 at 11:10 PM
CLASS ACTION UPDATE for NFLX, KPTI and CAH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for NFLX, KPTI and CAH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - August 22 at 11:10 PM
Karyopharm down 1% premarket on publication of mid-stage selinexor data in treatment-resistant multiple myelomaKaryopharm down 1% premarket on publication of mid-stage selinexor data in treatment-resistant multiple myeloma
seekingalpha.com - August 22 at 9:28 AM
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: What is a Special Dividend?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel